|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| C12N 15/11 |
| (11) | Number of the document | 3067421 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16154927.4 |
| Date of filing the European patent application | 2012-02-08 | |
| (97) | Date of publication of the European application | 2016-09-14 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161440828 P | 2011-02-08 | US | |
| 201161470927 P | 2011-04-01 | US | |
| 201161522659 P | 2011-08-11 | US |
| (72) |
FREIER, Susan, M., US
SWAYZE, Eric, E., US
|
| (73) |
Ionis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | OLIGOMERIC COMPOUNDS COMPRISING BICYCLIC NUCLEOTIDES AND USES THEREOF |
| OLIGOMERIC COMPOUNDS COMPRISING BICYCLIC NUCLEOTIDES AND USES THEREOF |